MacroGenics, Inc. (MGNX)

NASDAQ

$3.56

$+0.05

(+1.58%)

Regular Market

MacroGenics, Inc. (MGNX) Live Price Chart

Last updated: ⁦2026-10-21 16:24:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

MacroGenics, Inc. (MGNX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.56, with a market capitalization of $212.12M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.29 to $5.08. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$212.12M
Open	$3.45
Day's High	$41.00
Day's Low	$0.99
Previous Close	$3.49
Volume	124.97K
Average Volume	579.32K
P/E Ratio	--
52-Week High	$5.08
52-Week Low	$1.29
Dividend Yield	--
Earnings Date	--

MacroGenics, Inc. (MGNX) Stock Price Today

MacroGenics, Inc. (MGNX) is currently trading at $3.56 as of 2026-10-21 16:23:00, up 1.86% ($0.06) from the previous close of $3.49

During today's regular trading session, MGNX has traded between $0.99 and $41.00, with a trading volume of 124.97K shares. The current price is near the lower end of today's range.

MacroGenics, Inc. (MGNX) 7-Day Stock Price Change

Over the past seven days, MacroGenics, Inc. (MGNX) moved from $3.72 to $3.56, representing a decline of 4.44% ($0.17).

The stock traded between $3.12 and $3.76 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.

The average daily volume was 518.90 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

MGNX 52-Week Price Position

Position in Range: 59.8%

52W Low$1.29

52W High$5.08

MGNX is currently trading at $3.56, placing it 59.8% of the way from its 52-week low of $1.29 to its 52-week high of $5.08. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is MacroGenics, Inc. (MGNX)?

Macrogenics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of cancer. The company is currently developing therapeutics utilizing multiple modalities, including antibody-drug conjugates (ADCs) and multi-specific antibodies (which it refers to as DART and TRIDENT molecules). It is advancing three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload. Its segment is developing and commercializing monoclonal antibody-based therapeutics.

MacroGenics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	293
Exchange	NASDAQ
Company Website	https://www.macrogenics.com

How to Buy MacroGenics, Inc. (MGNX) Stock on MEXC

Eligible investors can buy real shares of MacroGenics, Inc. (MGNX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for MGNX and Place Your Order

Open the RealStocks trading page and search for MGNX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is MacroGenics, Inc. (MGNX) stock price today?

MacroGenics, Inc. (MGNX) is currently trading at $ 3.56, up 1.86% ($0.06) from the previous close of $ 3.49. Intraday prices update in real time during regular trading hours.

2.Is MGNX stock going up or down today?

As of 2026-10-21 16:23:00, MGNX is trading at $ 3.56, up 1.86% ($0.06) from its previous close of $ 3.49. The stock has traded between $ 0.99 and $ 41.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is MGNX pre-market price?

As of 2026-10-21 16:23:00, MGNX is trading at $ 3.37 in pre-market trading, down 3.32% ($0.12) from the previous close of $ 3.49. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is MGNX after-hours price?

As of 2026-10-21 16:23:00, MGNX is trading at $ 3.49 in after-hours trading, unchanged from the regular-session close of $ 3.49. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is MGNX stock trading now?

MGNX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does MGNX sit relative to its 52-week high and low?

Over the past 52 weeks, MGNX has traded between a low of $ 1.29 and a high of $ 5.08. At $ 3.56, the stock is positioned 59.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is MacroGenics, Inc. in?

MacroGenics, Inc. (MGNX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is MacroGenics, Inc.'s market capitalization and where is it listed?

MacroGenics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 212.12M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is MGNX valued in terms of P/E ratio and EPS?

MGNX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.23. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does MacroGenics, Inc. pay a dividend?

MacroGenics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.